99 related articles for article (PubMed ID: 17889464)
21. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
[TBL] [Abstract][Full Text] [Related]
22. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
23. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
24. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
[TBL] [Abstract][Full Text] [Related]
25. Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations.
Casadei MA; Cerreto F; Cesa S; Giannuzzo M; Feeney M; Marianecci C; Paolicelli P
Int J Pharm; 2006 Nov; 325(1-2):140-6. PubMed ID: 16846705
[TBL] [Abstract][Full Text] [Related]
26. Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics.
Guan T; Miao Y; Xu L; Yang S; Wang J; He H; Tang X; Cai C; Xu H
Int J Pharm; 2011 May; 410(1-2):180-7. PubMed ID: 21414393
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
[TBL] [Abstract][Full Text] [Related]
28. Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles.
Ruktanonchai U; Sakulkhu U; Bejrapha P; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
J Microencapsul; 2009 Nov; 26(7):614-26. PubMed ID: 19839797
[TBL] [Abstract][Full Text] [Related]
29. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
Yuan H; Miao J; Du YZ; You J; Hu FQ; Zeng S
Int J Pharm; 2008 Feb; 348(1-2):137-45. PubMed ID: 17714896
[TBL] [Abstract][Full Text] [Related]
30. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
31. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
Subedi RK; Kang KW; Choi HK
Eur J Pharm Sci; 2009 Jun; 37(3-4):508-13. PubMed ID: 19406231
[TBL] [Abstract][Full Text] [Related]
33. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
[TBL] [Abstract][Full Text] [Related]
34. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
35. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles.
Wang T; Wang N; Zhang Y; Shen W; Gao X; Li T
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):254-61. PubMed ID: 20447810
[TBL] [Abstract][Full Text] [Related]
36. Development and pharmacokinetics of nimodipine-loaded liposomes.
Wang Z; Deng Y; Zhang X; Wang T; Wu F
J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
[TBL] [Abstract][Full Text] [Related]
37. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
38. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
[TBL] [Abstract][Full Text] [Related]
39. PLA/PLGA nanoparticles for sustained release of docetaxel.
Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
[TBL] [Abstract][Full Text] [Related]
40. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
